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Objectives. To review the management of primary immunodeficiency
and discuss recent advances in genetic analysis.
Design. Retrospective study.
Setting. University teaching hospital, Hong Kong.
Patients. Children diagnosed with primary immunodeficiency and
followed up in the immunology clinic during the period 1988 to 2003.
Main outcome measures. Demographic data, co-morbidities and treat-
ment of patients, outcome and complications; identification of disease by
genetic mutations.
Results. Medical records of a total of 117 patients (72 male, 45 female)
diagnosed with primary immunodeficiency in the Department of Paediat-
rics and Adolescent Medicine, Queen Mary Hospital, Hong Kong during
the past 15 years (1988-2003) were reviewed. All patients were followed
up in the immunology clinic. Some patients had been referred from the
private sector or other hospitals for immunological workup. Six catego-
ries of primary immunodeficiency were identified: predominantly humoral
defect (n=50), predominantly cellular defect (n=22), combined humoral
and cellular defect (n=5), phagocytic defect (n=18), complement disor-
ders (n=4), and others (n=18). Although infection was the underlying
cause of most co-morbidities and mortality, autoimmune (n=7) and
allergic (n=23) manifestations were common. In addition, three patients
developed lymphoma. Recent advances in the genetic diagnosis of
several types of primary immunodeficiency were also reviewed: X-linked
Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease,
X-linked agammaglobulinaemia, X-linked lymphoproliferative syndrome,
leukocyte adhesion disease type I, and X-linked hyperimmunoglobulin
M syndrome. This provides an invaluable means of understanding the
molecular basis of primary immunodeficiency and has important clinical
applications.
Conclusions. Co-morbidities like autoimmune disease and allergic
disease are common in patients with primary immunodeficiency and
should be carefully evaluated. Likewise, a diagnosis of primary immuno-
deficiency should be considered when evaluating patients with these
conditions. Rapid progress in the field of molecular genetics will enable
definite and early diagnosis, and more importantly, potential curative
therapy to be administered.
  !"#$%&'()*+,-./012)34#56
  !"
  !"#$%&
 NVUUOMMP !"#$%&'()*+,'(-. /01
 
Hong Kong Med J Vol 11 No 2 April 2005      91
Primary immunodeficiency in Hong Kong
Introduction
Primary immunodeficiency (PID) is one of the most
challenging disease categories in paediatric medicine.
Primary immunodeficiency registries worldwide
reveal an incidence of approximately 1 per 5000 live
births.1 Diagnosis is nonetheless often delayed or
missed, despite an abundance of literature on the
subject. A high index of suspicion should thus be
maintained so that the condition can be promptly
diagnosed with early initiation of prophylactic treat-
ment or curative therapy, for example, haemopoietic
stem cell transplantation. In addition, an enhanced
molecular understanding of the disease allows earlier
diagnosis, and thus improves treatment options and
consequent clinical outcomes. This has important
implications for genetic counselling and prenatal
diagnosis.
A previous paper reviewed the magnitude of the
problem in this centre.1 The general principles of
management of PID and the outcome were discussed.
In this paper, recent advances in molecular genetics
are also described. The ability to detect specific muta-
tions allows confirmation of a genetic defect and
enables disease detection both prenatally and in other
family members. Immunological assessment should
not be confined to infection but should also include
associated autoimmune and allergic disorders.
Methods
A total of 117 patients were identified by retrospect-
ive review of medical records from July 1988 to
December 2003. Patients had a confirmed diagnosis
of PID, supported by clinical manifestations and labo-
ratory findings. All patients were followed up at the
immunology clinic. As a tertiary referral centre, many
cases were from the private sector or other hospitals.
The diagnosis of PID was established according to the
World Health Organization criteria.
Laboratory analysis included complete blood
picture, blood smear, immunoglobulin (Ig) levels,
isohaemagglutinins, functional post-vaccination
antibody response (eg anti-poliovirus, anti-tetanus,
anti-diphtheria, and anti-hepatitis B virus antibodies),
nitro-blue tetrazolium test, haemolytic titration of
complement (C3, C4, CH50), and Factor B. Further
tests, if indicated, included assessment of IgG
subclasses, lymphocyte subpopulations, proliferation
of T cells to mitogens, T and B cell function test, T
cell receptor rearrangement, CD-40 ligand assay,
natural killer cell function, cytokines profile, and
granulocyte function tests (eg chemotaxis,
phagocytosis, and bactericidal activity).
Genomic DNA and, if necessary, total RNA, were
isolated from the peripheral blood of patients and their
family members. Batch analysis of mutations was
performed using single-strand conformation polymorph-
ism with subsequent DNA sequencing. Polymerase
chain reaction–direct sequencing has recently been
applied for single newly identified cases to allow more
flexible and efficient diagnosis.
Haemopoietic stem cell transplantation is appro-
priate for PID disorders that result from defects intrin-
sic to cells of the haemopoietic lineages and that
are potentially fatal. Type of transplantation performed,
disease category, type of donor, and clinical outcome
were identified.
Results
Six categories of PID were identified: predominantly
humoral defect (n=50; 43%), predominantly cellular
defect (n=22; 19%), combined humoral and cellular
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defect (n=5; 4%), phagocytic defect (n=18; 15%),
complement disorders (n=4; 3%), and others (n=18;
15%). Humoral deficiency represented the most
common type of PID (Table 1). There were 72 males
and 45 females, with a male:female ratio of 1.6:1.
Thirteen patients died during the observation period,
six from overwhelming infection, four from compli-
cations associated with bone marrow transplantation
(two because of sepsis and interstitial pneumonitis,
another two because of severe graft versus host dis-
ease [GvHD]), one had Epstein-Barr virus (EBV)–
driven lymphoproliferative disease, one had end-stage
bronchiectasis, and one died from an unrelated cause.
Haemopoietic stem cell transplantation was
performed in 19 patients. Unrelated (matched) bone
marrow transplantation failed twice in one patient
with chronic granulomatous disease (CGD). This
patient is currently receiving maintenance therapy with
gamma interferon, cotrimoxazole, and itraconazole.
Table 2 shows the distribution of various types of stem
cell transplantation performed and the outcome.
Seven (6%) patients developed concomitant
autoimmune disease, including juvenile idiopathic
arthritis (n=2), insulin-dependent diabetes mellitus
(n=1), autoimmune hepatitis (n=1), Bechets’ disease
(n=2), and autoimmune haemolytic anaemia/throm-
bocytopenia (n=1). Underlying diseases included
CGD (n=1), IgG subclass deficiency (n=1), common
variable immunodeficiency (CVID; n=2), natural killer
cell deficiency (n=1), CD4 lymphopenia (n=1), and
Wiskott-Aldrich syndrome (WAS; n=1). Allergic
disease requiring treatment developed in 23 (20%)
patients, approximately half of whom had IgG sub-
class deficiency (Table 3).
Lymphoma occurred in three patients. One patient
with WAS developed B-cell lymphoma and underwent
bone marrow transplantation from a matched unrelated
donor. He remained in remission. Another patient
with ataxia telangiectasia developed centroblastic B-
cell lymphoma and ultimately died of end-stage
bronchiectasis. Another patient with CVID developed
mucosa-associated lymphoid tissue B-cell lymphoma
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Table 1.  Occurrence and mortality of primary immunodeficiency disorders
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of the lung that was treated with chemotherapy,
followed by a matched unrelated bone marrow
transplantation. She ultimately died of severe chronic
GvHD following the bone marrow transplantation.
Detection of gene mutations has recently been
increasingly successful. In X-linked agammaglobu-
linaemia (XLA), mutation of the XLA causative
gene (Bruton’s tyrosine kinase gene) results in a
defect of Bruton’s tyrosine kinase, the protein respon-
sible for development and function of B cells and
their progeny. Protection from maternal antibodies
slowly declines to a nadir by age 4 to 6 months, thus
patients are susceptible to recurrent pyogenic infec-
tion. Local data suggested that patients experienced
their first infection before the age of 14 months,2
but that the diagnosis was delayed in most with a
median age at diagnosis of 5.8 years. Respiratory tract
infection was most commonly encountered followed
by gastro-intestinal tract infection. Haemophilus
influenzae infection was the most commonly isolated
organism. In the author’s unit, monthly intravenous
immunoglobulin was administered to all patients
with a consequent significant reduction in infection
rate as well as improvement in overall growth. None-
theless bronchiectasis occurred in three of 11 patients
in whom diagnosis was delayed until the age of 6 to
14 years.
Detection of the mutant Bruton’s tyrosine kinase
gene, which was mapped at Xq21.3-22, has been
performed.3 Of the eight mutations shown in Table 4,
six are novel.
Wiskott-Aldrich syndrome is an X-linked recessive
disease characterised by recurrent infection, eczema,
and thrombocytopenia with small-sized, poorly
functioning platelets. The gene locus for WAS has been
mapped to the short arm of X chromosome, Xp11.23-
11.22. The disease is caused by mutation of the gene
encoding the WAS protein. Patients have recurrent
pyogenic infection beginning in the first year of life.
In a previous review, all patients presented within
the first month of life with severe eczema and fre-
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Table 2.  Type of haemopoietic stem cell transplant performed and outcome
* SCID denotes severe combined immunodeficiency, WAS Wiskott-Aldrich syndrome, XHIM X-linked hyperimmunoglobulin M syndrome,
CGD chronic granulomatous disease, XLP X-linked lymphoproliferative disease, and CVID common variable immunodeficiency
† GvHD graft versus host disease
‡ Died of cause unrelated to immunodeficiency or transplantation
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Table 3.  Occurrence of co-morbidities
* CGD denotes chronic granulomatous disease, IgG immunoglobin G, NK natural killer, CVID common variable immunodeficiency, and WAS
Wiskott-Aldrich syndrome
*
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quent life-threatening infection.4 Six novel mutations
were identified (Table 5).4,5
Chronic granulomatous disease is a group of
genetic disorders characterised by recurrent infec-
tion with catalase positive organisms of the re-
spiratory tract, skin, and soft tissue. Underlying X-
linked CGD (XCGD) is a defect in the gp91phox-
gene on Xp21.1. The median age of diagnosis in this
study was 1.2 years (range, 0.16-11.3 years); most
children (75%) experienced their first infection before
6 months of age. Lower respiratory tract infection
was most common, followed by gastro-intestinal
tract infection. Patients usually have a poor long-term
prognosis with median survival dropping from 66%
at 11 years old to 50% at 20 years old. Current
management of such patients involves prophy-
lactic cotrimoxazole, itraconazole and interferon-
gamma, and aggressive management of any infection
when it occurs. Matched unrelated bone marrow
transplantation was performed in two patients: one
died from severe GvHD and the other had two failed
grafts. Table 6 summarises the mutations found in
this study.
Boys affected by X-linked lymphoproliferative
disease (XLP) exhibit a progressive combined form
of immunodeficiency characterised by proliferation
of lymphocytes, histiocytes, and alterations in con-
centration of serum immunoglobulins. There is also
a catastrophic response to infection with EBV. The
gene responsible for XLP is known as SAP (Signalling
lymphocytic activation molecule–Associated Protein).
In one patient with XLP, a large deletion of the whole
gene was discovered. After unrelated cord blood
transplantation, the patient had normal gene expres-
sion and was considered cured. An older brother who
died from an EBV-driven lymphoproliferative disease
almost certainly had the same disease.
X-linked hyper-IgM syndrome results from defects
in the CD40 ligand gene that prevents it from deliver-
ing an activation signal to antigen-presenting cells
via CD40. One patient suffering from the disorder
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Table 4.  Mutations in X-linked agammaglobulinaemia
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had C→A nonsense substitution mutation at nucleotide
position 710 of exon 5 and ended up with a stop codon
instead of a cysteine.
In the patient with leukocyte adhesion deficiency
type I (LADI), who presented with persistent omphali-
tis and recurrent soft tissue infections, compound
heterozygous novel mutations of CD18 were detected
in exon 4 and 14 respectively.6,7 Predicted frameshift
and premature termination of protein synthesis are
expected.
Discussion
It is estimated that approximately 50% to 60% of
PID disorders involve humoral immunity, 10% to
15% cell-mediated immunity, 15% to 20% com-
bined humoral and cellular immunity, 10% to 15%
phagocytic immunity, and 1% to 3% the complement
system.8 The authors’ centre appeared to have fewer
cases of severe combined immunodeficiency (SCID)
compared with other centres. This may be due to the
small sample size. Some cases of SCID may also have
gone undiagnosed if death occurred in early infancy.
This review is a continuation of work published in
1999.1 Children suffering from PID continue to be
diagnosed and usually present with increased suscep-
tibility to infection. This may include an increased
frequency or severity of infection, or the presence of
unusual infecting organisms or unexpected com-
plications. The Jeffrey Modell Foundation, a research
foundation for PID, has proposed eight warning
signs for PID: eight or more than eight episodes of
otitis media per year, two or more than two episodes
of severe sinusitis, pneumonia or deep-seated infec-
tion per year, recurrent deep abscesses and persistent
candidiasis occurring after the age of 1 year. Incom-
plete response to treatment and need for intravenous
antibiotics are other indications. The list is by no means
complete; physicians should thus maintain a high
index of suspicion. Certain clinical patterns should also
be recognised and may assist in specifically diagnos-
ing PID.1 For example, a newborn who presents with
delayed umbilical cord detachment, leukocytosis, and
recurrent soft tissue infection is likely to have leukocyte
adhesion deficiency. Further examples and informa-
tion are readily available from the Immune Deficiency
Foundation website: http://www.primaryimmune.org.
It is worth noting that in a number of cases, infec-
tion may not be the presenting complaint that alerts
a doctor to the possibility of PID. A 4-year-old girl
recently diagnosed with IgG subclass deficiency
was originally referred for investigation of immune
function because of an unusually aggressive course
of eczema. The association between PID and allergy
is well established. In particular, IgA deficiency is
associated with the development of allergies, such
as allergic conjunctivitis, rhinitis, urticaria, eczema,
and asthma; and IgE levels are noted to increase in
IgA deficiency.9 Immunoglobulin G subclass defi-
ciency has been noted in patients with food allergy,
asthma, and other autoimmune diseases.10 In a retro-
spective study carried out in Taiwan, autoimmune
diseases associated with allergic disease included
juvenile idiopathic arthritis, ulcerative colitis, and
autoimmune haemolytic anaemia.11 In this review,
seven patients had other pre-existing conditions. The
diagnosis of PID should thus be kept in mind when
evaluating patients with autoimmune or allergic
disease, and vice versa.
The mechanism of the link between PID and
allergic disease remains unresolved. Three mechanisms
have been proposed12: persistent bacterial or viral
infection due to failure of the body to clear an infec-
tion may cause continued activation of the innate
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immune system resulting in autoimmune disease;
impaired phagocytosis leading to failure to clear im-
mune complexes may cause a variety of autoimmune
problems; finally, dysregulation of lymphocyte
homeostasis. A thorough understanding of the regula-
tion and production of lymphokines is essential to elu-
cidating the underlying pathogenesis of autoimmunity.
One of the mainstays of management of PID is
prescription of antimicrobials, for prophylaxis or
therapy. Intravenous immunoglobulin replacement
therapy is also  administered to patients with antibody
immunodeficiency or combined antibody and cellular
immunodeficiency. Bone marrow transplantation
has enabled long-term survival for some patients,
usually those with SCID or WAS.13
In the last 10 years, great progress has been made
in understanding the molecular aspects of PID.
More than 100 distinct immunodeficiency disorders
have been elucidated and the molecular genetic basis
characterised in more than 75%.12 The first main
benefit of mutation detection is the direct test that
it offers to other patients a fast and definitive means
of diagnosis. The problem of getting equivocal results
and the subsequent need for repeated testing is avoided.
Children can be screened at a young age to enable
early diagnosis and treatment and thus ensure the
best prognosis. Future research into phenotype/geno-
type correlation may identify indicators of future
disease severity. This has been studied in relation to
WAS protein: different forms of mutation can result
in classic WAS or in the less severe form, X-linked
thrombocytopenia.
Knowledge of mutations aids in the diagnosis of
carriers and plays a vital role in genetic counselling.
Prenatal diagnosis allows families to better consider
their options. The technique can even be extrapolated
to preimplantation genetic diagnosis. Molecular genet-
ics will also be of benefit to future gene therapy study.
Worldwide research on the molecular genetics of
PID is making a global registry possible. IDdiagnotics
is an on-line database for mutation registry that
enables physicians to refer patients to centres that
offer genetic services. The authors’ department
offers genetic testing for five PIDs: WAS, XLA, XLP,
XCGD, and LADI (http://bioinf.uta.fi/IDdiagnostics/
xindex.shtml).
Major advances in the molecular understanding
of many PIDs as well as an understanding of their
association with autoimmune and allergic diseases
enhance the management of affected patients.
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